Delayed Use of ChatGPT by Japanese Doctors Due to Limited English Language Proficiency: A Survey-Based Study in Japan

日本医生因英语水平有限而延迟使用 ChatGPT:一项基于日本的调查研究

阅读:1

Abstract

BACKGROUND: Artificial intelligence (AI) systems, such as Chat Generative Pretrained Transformer (ChatGPT), can provide efficient medical support for doctors. However, the adoption of ChatGPT may depend on users' proficiency in English. In this study, we surveyed the use of ChatGPT by early-career doctors, especially those working in rural areas of Japan. METHODS: We conducted an anonymous online survey targeting early-career doctors (one to nine years of clinical experience) in Japan. The survey was conducted between October 10 and December 31, 2024. Participants were asked to provide their demographic information, experience using ChatGPT, and the benefits and challenges of using it. RESULTS: Forty-six physicians completed the questionnaire. Of the respondents, 32.6% (15/46) had never used ChatGPT. Among the users, only 12.9% (4/31) began using the English version of ChatGPT before the Japanese version became available. Supporting the writing of academic papers in English was the most frequently cited benefit of ChatGPT among respondents, as reported by 18 users. DISCUSSION: Our findings suggest a potential link between limited English proficiency and delayed initial adoption of ChatGPT among early-career Japanese doctors. Nevertheless, they supported Japanese doctors in their academic writing. These findings underscore the need to introduce targeted efforts to promote ChatGPT, particularly in non-English-speaking communities. Although AI is associated with some ethical concerns, this study highlights the utility of ChatGPT for this population. CONCLUSION: Our findings suggest a potential link between limited English proficiency and the delayed initial adoption of ChatGPT among early-career Japanese doctors.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。